Medication-related osteonecrosis of the jaw in a breast cancer patient receiving denosumab for bone metastases: a case report
Year: 2025
Type: article
Study design: Case Report
Abstract: The use of bone-modifying agents in cancer patients to prevent skeletal-related complications associated with bone metastases has been linked to an increased risk of medication-related osteonecrosis of the jaw (MRONJ). In oncologic settings, bone-modifying agents are typically administered at higher doses and shorter intervals than those used for osteoporosis, thereby further elevating MRONJ risk. We report a case of MRONJ in a breast cancer patient receiving denosumab for metastatic bone disease, which was successfully managed with conservative treatment.
Source: Kosin Medical Journal
DOI: 10.7180/kmj.25.133
Author: Min-Kyeong Kim
Language: English
Topic: Bone health and treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7117297445